Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-25

Clinical Trial Update: A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of pregabalin for fibromyalgia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED